The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of elderly patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor T-cell (CAR-T) therapy.
 
Lindsey Fitzgerald
No Relationships to Disclose
 
Adam Kittai
No Relationships to Disclose
 
Loretta J. Nastoupil
Honoraria - Bayer; Celgene; Gamida Cell; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Novartis; Pfizer; Spectrum Pharmaceuticals; TG Therapeutics
Research Funding - Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; LAM Therapeutics; TG Therapeutics
 
Alexandra Waller
No Relationships to Disclose
 
Caron A. Jacobson
Honoraria - Kite/Gilead
Consulting or Advisory Role - Bayer; Kite/Gilead; Novartis; Pfizer; Precision Biosciences
Speakers' Bureau - Cowen
Travel, Accommodations, Expenses - Bayer; Cowen; Kite/Gilead; Novartis; Pfizer
 
Anna Saucier
No Relationships to Disclose
 
Manali K. Kamdar
Consulting or Advisory Role - AstraZeneca; Celgene; Pharmacyclics/Janssen
Speakers' Bureau - Seagen
 
Janet Spradley
No Relationships to Disclose
 
Nathan Denlinger
No Relationships to Disclose
 
Jonathan Chipman
No Relationships to Disclose
 
Boyu Hu
No Relationships to Disclose